Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Michael Geffner Insider Profile
4 Followers
Michael Geffner, CMO at Immunovant, holds 134.97K shares in Immunovant (Ticker: IMVT). Most recently, Michael Geffner Sold $3,189 shares of Immunovant on Oct 25, 2024 for an estimated value of 94.17K.
Profitable Transactions
1 out of 4 Profitable Transactions
Average Return
+0.60%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Michael Geffner's holdings
Insider Roles
CMO
Roles that Michael Geffner holds in companies
Most Profitable Insider Trade
The most profitable trade made by Michael Geffner
Michael Geffner's Trading History
List of latest transactions for each holding click on a transaction to see Michael Geffner's performance on stock
You May Also Like
Michael Geffner insider profile FAQ
What is the percentage of profitable transactions made by Michael Geffner?
The percentage of profitable transactions made by Michael Geffner is 25%.
What is the average return per transaction made by Michael Geffner?
The average return per transaction made by Michael Geffner is 0.60%.
What stocks does Michael Geffner hold?
Michael Geffner holds: IMVT stocks.
What was Michael Geffner’s latest transaction?
Michael Geffner latest transaction was an Informative Sell of $94.17K.
What was Michael Geffner's most profitable transaction?
Michael Geffner’s most profitable transaction was an Informative Sell of IMVT stock on January 29, 2024. The return on the trade was 22.00%.
What is Michael Geffner's role in Immunovant?
Michael Geffner's role in Immunovant is CMO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.